These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8288207)

  • 21. Evaluation of the dissolution behaviour of some commercial herbal drugs and their preparations.
    Taglioli V; Bilia AR; Ghiara C; Mazzi G; Mercati V; Vincieri FF
    Pharmazie; 2001 Nov; 56(11):868-70. PubMed ID: 11817172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bioavailability of norfloxacin tablets based on blood and urine data.
    Nada AH; Sharaf MA; El Gholmy ZA; Khalafallah NM
    Med Princ Pract; 2007; 16(6):426-31. PubMed ID: 17917441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between dissolution rate and bioavailability of paracetamol tablet.
    Huang XP; Wan XX; Liu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of UV spectrophotometric method and high performance liquid chromatography for the analysis of flunarizine and its application for the dissolution test.
    Busaranon K; Suntornsuk W; Suntornsuk L
    J Pharm Biomed Anal; 2006 Apr; 41(1):158-64. PubMed ID: 16352415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation.
    Khiljee S; Ahmad M; Murtaza G; Madni A; Akhtar N; Akhtar M
    Pak J Pharm Sci; 2011 Oct; 24(4):421-6. PubMed ID: 21959800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of diarrhoeal disease on the pharmacokinetics of norfloxacin.
    Bergan T; Lolekha S; Cheong MK; Poh CL; Patancharoen S
    Scand J Infect Dis Suppl; 1988; 56():11-3. PubMed ID: 3249925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of polyvinylpyrrolidone on the solution and bioavailability of hydrochlorothiazide.
    Corrigan OI; Timoney RF; Whelan MJ
    J Pharm Pharmacol; 1976 Sep; 28(9):703-6. PubMed ID: 10394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
    Koch HP; Alcorn G; Ritschel WA
    Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
    Ammar HO; Khalil RM; Omar SM
    Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diglyceride prodrug strategy for enhancing the bioavailability of norfloxacin.
    Dhaneshwar S; Tewari K; Joshi S; Godbole D; Ghosh P
    Chem Phys Lipids; 2011 May; 164(4):307-13. PubMed ID: 21477584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bioavailability of ampicillin preparations for internal use].
    Zak AF; Batuashvili TA; Shchedrin VI
    Antibiotiki; 1980 Jan; 25(1):24-8. PubMed ID: 7356297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, Characterization and Antimicrobial Evaluation of Lipid Based Norfloxacin Prodrug.
    Sharma PC; Piplani M; Rajak H
    Curr Drug Deliv; 2018 Feb; 15(2):219-226. PubMed ID: 27758690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of milk on absorption of norfloxacin in healthy volunteers.
    Minami R; Inotsume N; Nakano M; Sudo Y; Higashi A; Matsuda I
    J Clin Pharmacol; 1993 Dec; 33(12):1238-40. PubMed ID: 8126259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nifedipine preparations on the Belgian market: a comparative study.
    De Braekeleer K; Fierens C; Corthout J
    J Pharm Belg; 2009 Dec; (4):141-6. PubMed ID: 20183991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
    Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
    J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.